{"lastClose": 10.4399995803833, "len": 1224, "date": "2023-04-05", "alpha_1": 0.5666913086225096, "beta_1": 0.8283731632276388, "drawup_1": 1.2434209803960319, "sharpe_1": 0.20932005766407918, "natr_1": 6.43807781546782, "sup_1": -0.22509577012842852, "res_1": 0.05124522862135064, "bullPattern_1": [], "bearPattern_1": ["3OUTSIDE"], "rsi_1": 31.361764016418935, "adx_1": 36.302762078140326, "drawdown_1": -0.3876832816689805, "stratHoldSharpe_1": 0.18852170867417575, "stratHoldAlpha_1": 251.09892757784246, "stratHoldDrawdown_1": -0.3620374844050709, "alpha_3mo": -0.770199953069173, "beta_3mo": 0.6042890717906566, "drawup_3mo": 0.054466229126168386, "natr_3mo": 6.43807781546782, "sup_3mo": -0.04118770945171965, "res_3mo": 0.15613031588575146, "bullPattern_3mo": [], "bearPattern_3mo": ["3OUTSIDE", "SHORTLINE"], "rsi_3mo": 32.88590668461366, "adx_3mo": 64.65251932593831, "drawdown_3mo": -0.314510840828934, "stratHoldSharpe_3mo": -3.9973915267189604, "stratHoldAlpha_3mo": 249.7256224639753, "stratHoldDrawdown_3mo": -0.2837677772348318, "IPO Year": 2018.0, "Industry": "Biotechnology: Pharmaceutical Preparations", "Country": "United States", "Market Cap": 728222604, "Name": "Kiniksa Pharmaceuticals Ltd. Class A", "Sector": "Health Care", "alpha%_1": 0.9707164084804324, "beta%_1": 0.3751394457310096, "drawup%_1": 0.9729732283085628, "sharpe%_1": 0.3260000091646828, "natr%_1": 0.8229116914448302, "drawdown%_1": 0.4823768821914883, "stratHoldSharpe%_1": 0.6232108558774999, "stratHoldAlpha%_1": 0.6648778002023669, "stratHoldDrawdown%_1": 0.4590736017893106, "alpha%_3mo": 0.13289894037996192, "beta%_3mo": 0.2301752933566107, "drawup%_3mo": 0.1316892150210795, "natr%_3mo": 0.8145834431212249, "drawdown%_3mo": 0.16044797244339376, "stratHoldSharpe%_3mo": 0.01124930800582022, "stratHoldAlpha%_3mo": 0.01771512705281468, "stratHoldDrawdown%_3mo": 0.16674655540406685}